Spark-BIH

News

Start-up EpiBlok founded by SPARKEE Prof. Heilbronn

EpiBlok Therapeutics GmbH is developing a gene therapy for epilepsy

HTGF supports SPARK-BIH pitch training workshop

Dr. Angelika Vlachou, Principal at High-Tech Gründerfonds (HTGF), supported 25 translational SPARK project teams with a dedicated hands-on Pitch Training Workshop.

OPEN for applications: SPARK-BIH & NeuroCure/SPARK Call 2022

APPLY NOW! We offer funding and coaching to support your translational project.

NeuroCure Design Thinking workshop

SPARK-BIH and NeuroCure organized a second Design Thinking workshop.

NeuroCure/SPARK Call 2022

After the successful implementation of the NeuroCure/SPARK program, NeuroCure and SPARK-BIH prolong their collaboration and will run a second call for projects.

Cholesterol-lowering drugs may slow down metastases

Researchers led by our SPARKee Ulrike Stein of the ECRC and Robert Preißner of Charité report in "Clinical and Translational Medicine" that statins inhibit a gene that promotes cancer cell metastasis.

Second funding round for NeuroCure/SPARK-BIH teams

NeuroCure grants funding extension to the four NeuroCure/SPARK-BIH teams for an additional year.

Podcast Startup DNA with Myopax

Our SPARKees Simone Spuler und Verena Schöwel present their startup MyoPax in Frank Thelen's Podcast Startup-DNA.

Our Mission

We are a mentoring network aiming to accelerate the translation of academic inventions into clinically relevant drugs, diagnostics and medical devices.

SPARK Concept

For inventors

Validate your research findings and translate them into therapies, products or services to help patients.

Application

For mentors & advisors

Share your expertise with our SPARKees and participate in our program as SPARK advisor.

Accelerating medical solutions

News

Our Mission

For inventors

For mentors & advisors